Literature DB >> 21930853

Health care system delay and heart failure in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: follow-up of population-based medical registry data.

Christian Juhl Terkelsen1, Lisette Okkels Jensen, Hans-Henrik Tilsted, Sven Trautner, Søren Paaske Johnsen, Werner Vach, Hans Erik Bøtker, Leif Thuesen, Jens Flensted Lassen.   

Abstract

BACKGROUND: In patients with ST-segment elevation myocardial infarction (STEMI), delay between contact with the health care system and initiation of reperfusion therapy (system delay) is associated with mortality, but data on the associated risk for congestive heart failure (CHF) among survivors are limited.
OBJECTIVE: To evaluate the association between system delay and the risk for readmissions or outpatient contacts due to CHF after primary percutaneous coronary intervention (PPCI) in patients with STEMI.
DESIGN: Historical follow-up study using population-based medical registries.
SETTING: Western Denmark. PATIENTS: Patients with STEMI who were transported by emergency medical service from 1 January 1999 to 7 February 2010 and treated with PPCI within 12 hours of symptom onset and who had a system delay of 6 hours or less (n = 7952). The median duration of follow-up was 3.1 years. MEASUREMENTS: Cumulative incidence of readmissions or outpatient contacts due to CHF was determined by using competing-risk regression analysis, with death as the competing risk. Crude and adjusted cause-specific hazard ratios for readmissions or outpatient contacts due to CHF were determined for system delay and other covariates.
RESULTS: System delays of 60 minutes or less (n = 451), 61 to 120 minutes (n = 3457), 121 to 180 minutes (n = 2655), and 181 to 360 minutes (n = 1389) corresponded with long-term risks for readmissions or outpatient contacts due to CHF of 10.1%, 10.6%, 12.3%, and 14.1%, respectively (P < 0.001). In multivariable analysis, system delay was an independent predictor of readmissions or outpatient contacts due to CHF (adjusted hazard ratio per hour increase in delay, 1.10 [95% CI, 1.02 to 1.17]). LIMITATION: In any nonrandomized study, there are risks for selection bias and residual confounding.
CONCLUSION: In patients with STEMI, shorter delay to PPCI is associated with lower risk for readmissions or outpatient contacts due to CHF during follow-up.

Entities:  

Mesh:

Year:  2011        PMID: 21930853     DOI: 10.7326/0003-4819-155-6-201109200-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  22 in total

Review 1.  Opportunities for cost reduction of medical care: part 3.

Authors:  Monte Malach; William J Baumol
Journal:  J Community Health       Date:  2012-08

2.  Pharmacologic reperfusion therapy with indigenous tenecteplase in 15,222 patients with ST elevation myocardial infarction - the Indian Registry.

Authors:  S S Iyengar; T Nair; J S Hiremath; U Jadhav; V K Katyal; D Kumbla; I Sathyamurthy; R K Jain; M Srinivasan
Journal:  Indian Heart J       Date:  2013-07-10

Review 3.  Timely and optimal treatment of patients with STEMI.

Authors:  Jens F Lassen; Hans E Bøtker; Christian J Terkelsen
Journal:  Nat Rev Cardiol       Date:  2012-11-20       Impact factor: 32.419

4.  Reperfusion delay in patients treated with primary percutaneous coronary intervention: insight from a real world Danish ST-segment elevation myocardial infarction population in the era of telemedicine.

Authors:  Mikkel M Schoos; Maria Sejersten; Anders Hvelplund; Mette Madsen; Jacob Lønborg; Jacob Steinmetz; Philip M Treschow; Frants Pedersen; Erik Jørgensen; Peer Grande; Henning Kelbæk; Peter Clemmensen
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-09

Review 5.  Novel adjunctive treatments of myocardial infarction.

Authors:  Michael Rahbek Schmidt; Kasper Pryds; Hans Erik Bøtker
Journal:  World J Cardiol       Date:  2014-06-26

6.  Searching myocardial rescue through intermittent upper arm occlusion and lizard saliva.

Authors:  Hans Erik Bøtker
Journal:  Basic Res Cardiol       Date:  2021-01-25       Impact factor: 17.165

7.  Primary Percutaneous Coronary Intervention Facility Hospitals and Easy Access Can Affect the Outcomes of ST-Segment Elevation Myocardial Infarction Patients.

Authors:  Mohammed Ali Balghith
Journal:  Heart Views       Date:  2021-01-14

8.  Safety measures for COVID-19 do not compromise the outcomes of patients undergoing primary percutaneous coronary intervention: a single center retrospective study.

Authors:  Xiaonan Guan; Jianjun Zhang; Yanbing Li; Ning Ma
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

9.  Warning system improve the clinical outcomes in transfer patients with ST-segment elevation myocardial infarction.

Authors:  Hsiu-Yu Fang; Wei-Chieh Lee
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

10.  Impact of SARS-CoV-2 pandemic on ST-elevation myocardial infarction admissions and outcomes in a Portuguese primary percutaneous coronary intervention center: Preliminary Data.

Authors:  André Azul Freitas; Rui Baptista; Valdirene Gonçalves; Cátia Ferreira; James Milner; Carolina Lourenço; Susana Costa; Fátima Franco; Sílvia Monteiro; Francisco Gonçalves; Lino Gonçalves
Journal:  Rev Port Cardiol (Engl Ed)       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.